Form D — Shuttle Pharmaceuticals Holdings, Inc.
0001493152-26-023887 · filed 2026-05-15
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $9,955,000
- Total sold
- $9,955,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Shuttle Pharmaceuticals Holdings, Inc.
- CIK
- 1757499
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 401 PROFESSIONAL DRIVE
GAITHERSBURG, MD 20879 - Phone
- (240) 403-4212
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Cooper · Executive OfficerGAITHERSBURG, MD Find on LinkedIn ↗
-
George Scorsis · DirectorGAITHERSBURG, MD Find on LinkedIn ↗
-
Adam Chambers · DirectorGAITHERSBURG, MD Find on LinkedIn ↗
-
Yuying Liang · Executive OfficerGAITHERSBURG, MD Find on LinkedIn ↗
-
Angel Liriano · DirectorGAITHERSBURG, MD Find on LinkedIn ↗
-
Ryan Trasolini · Executive OfficerGAITHERSBURG, MD Find on LinkedIn ↗
View original on SEC EDGAR.